MCA stability tool

Check whether tablets and capsules are suitable for a multi-compartment compliance aid (MCA), and build a list to print.

Browse medicines A to Z

Medicines beginning with F

Ferrous sulfate

Ferrous sulfate 200mg tablets

Use with caution

Stability notes for Ferrous sulfate 200mg tablets

Moisture sensitive medicine. Store in airtight (sealed) MCA.   Protect from light.     No stability data in MCAs available.

Provenance

This recommendation is based on the products Ferrous sulfate 200mg tablets (Sanofi).

Suppliers (15) of Ferrous sulfate 200mg tablets
ActiFerr-S 200mg tablets (MaN Pharma Ltd)
FerroDose-S 200mg tablets (TriOn Pharma Ltd)
FerroTab 200mg tablets (Essential-Healthcare Ltd)
Ferrous sulfate 200mg tablets (A A H Pharmaceuticals Ltd)
Ferrous sulfate 200mg tablets (Accord-UK Ltd)
Ferrous sulfate 200mg tablets (Alliance Healthcare (Distribution) Ltd)
Ferrous sulfate 200mg tablets (Almus Pharmaceuticals Ltd)
Ferrous sulfate 200mg tablets (Medihealth (Northern) Ltd)
Ferrous sulfate 200mg tablets (Phoenix Healthcare Distribution Ltd)
Ferrous sulfate 200mg tablets (Sandoz Ltd)
Ferrous sulfate 200mg tablets (Sigma Pharmaceuticals Plc)
Ferrous sulfate 200mg tablets (Sun Pharma UK Ltd)
Ferrous sulfate 200mg tablets (Wockhardt UK Ltd)
Ferrous sulfate 200mg tablets (Zanza Specials International Ltd)
Purosure Ferrous sulfate 200mg tablets (Biovantic Pharma Ltd)

Ferrous sulfate 325mg modified-release tablets

Use with caution

Stability notes for Ferrous sulfate 325mg modified-release tablets

Protect from Moisture. Protect from light. No stability data in MCAs available.

Provenance

This recommendation is based on the products Ferrograd 325mg modified-release tablets (Teofarma S.R.L).

Supplier

Ferrograd 325mg modified-release tablets (Teofarma S.r.l.)

What the ratings mean

Compatible
Suitable for use. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label.
Use with caution
Suitable with mitigations. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label and supported by limited data.
Incompatible
Medicines under this category are not suitable for use in MCAs.
No stability information
These medicines have not been reviewed by SPS.